Repligen Licenses Potential Treatment for Spinal Muscular Atrophy Conference Call Scheduled for Friday, October 23 at 8:30 a.m. Press Release Source: Repligen Corporation On 4:00 pm EDT, Thursday October 22, 2009 Companies:Repligen Corporation WALTHAM, Mass.,
Oct. 22 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN - News) announced today that it has entered into an exclusive license ...